This news confirms succession not termination of the future of this drug.Sellers represent the day traders who regard this as another waiting period ,not a failure
This is a wonderful news for the company, have patience and buy at the dips, things will span out.
Smart investors sold,
Why wait around two years while Sunil dilutes the #$%$ out of the stock?
It will surely hit a new Low, before it recovers.
lucky_me2010: A new low would be .01 or less. Do you think anyone should take your prediction seriously?
Nope, this will start soaring once TTNP designs the clinical study. It has bottomed down at 0.57-0.58, approached oversold territory. Expect some analyst pumping the stock in the next week or two. Target price 1.50 within 6 months.